vs
Cytek Biosciences, Inc.（CTKB）与沃特世（WAT）财务数据对比。点击上方公司名可切换其他公司
沃特世的季度营收约是Cytek Biosciences, Inc.的15.0倍（$932.4M vs $62.1M）。沃特世净利率更高（24.2% vs -70.9%，领先95.1%）。Cytek Biosciences, Inc.同比增速更快（8.1% vs 6.8%）。过去两年沃特世的营收复合增速更高（21.0% vs 17.7%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
沃特世是总部位于美国马萨诸塞州米尔福德的企业，面向生命科学、材料、食品等行业，提供色谱、质谱、实验室信息学、流变测量领域所用的分析仪器及配套软件，为各领域的检测、研发等工作提供可靠技术支持。
CTKB vs WAT — 直观对比
营收规模更大
WAT
是对方的15.0倍
$62.1M
营收增速更快
CTKB
高出1.3%
6.8%
净利率更高
WAT
高出95.1%
-70.9%
两年增速更快
WAT
近两年复合增速
17.7%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $932.4M |
| 净利润 | $-44.1M | $225.2M |
| 毛利率 | 52.9% | 61.1% |
| 营业利润率 | -9.0% | 29.0% |
| 净利率 | -70.9% | 24.2% |
| 营收同比 | 8.1% | 6.8% |
| 净利润同比 | -557.1% | -2.7% |
| 每股收益（稀释后） | — | $3.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBWAT
| Q4 25 | $62.1M | $932.4M | ||
| Q3 25 | $52.3M | $799.9M | ||
| Q2 25 | $45.6M | $771.3M | ||
| Q1 25 | $41.5M | $661.7M | ||
| Q4 24 | $57.5M | $872.7M | ||
| Q3 24 | $51.5M | $740.3M | ||
| Q2 24 | $46.6M | $708.5M | ||
| Q1 24 | $44.9M | $636.8M |
净利润CTKBWAT
| Q4 25 | $-44.1M | $225.2M | ||
| Q3 25 | $-5.5M | $148.9M | ||
| Q2 25 | $-5.6M | $147.1M | ||
| Q1 25 | $-11.4M | $121.4M | ||
| Q4 24 | $9.6M | $231.4M | ||
| Q3 24 | $941.0K | $161.5M | ||
| Q2 24 | $-10.4M | $142.7M | ||
| Q1 24 | $-6.2M | $102.2M |
毛利率CTKBWAT
| Q4 25 | 52.9% | 61.1% | ||
| Q3 25 | 52.7% | 59.0% | ||
| Q2 25 | 52.3% | 58.3% | ||
| Q1 25 | 48.6% | 58.2% | ||
| Q4 24 | 58.5% | 60.1% | ||
| Q3 24 | 56.3% | 59.3% | ||
| Q2 24 | 54.6% | 59.3% | ||
| Q1 24 | 51.3% | 58.9% |
营业利润率CTKBWAT
| Q4 25 | -9.0% | 29.0% | ||
| Q3 25 | -17.6% | 24.0% | ||
| Q2 25 | -23.3% | 24.4% | ||
| Q1 25 | -36.1% | 22.9% | ||
| Q4 24 | 5.2% | 33.5% | ||
| Q3 24 | -8.2% | 28.5% | ||
| Q2 24 | -18.3% | 26.7% | ||
| Q1 24 | -23.9% | 21.0% |
净利率CTKBWAT
| Q4 25 | -70.9% | 24.2% | ||
| Q3 25 | -10.5% | 18.6% | ||
| Q2 25 | -12.2% | 19.1% | ||
| Q1 25 | -27.5% | 18.3% | ||
| Q4 24 | 16.8% | 26.5% | ||
| Q3 24 | 1.8% | 21.8% | ||
| Q2 24 | -22.4% | 20.1% | ||
| Q1 24 | -13.8% | 16.0% |
每股收益（稀释后）CTKBWAT
| Q4 25 | — | $3.76 | ||
| Q3 25 | — | $2.50 | ||
| Q2 25 | — | $2.47 | ||
| Q1 25 | — | $2.03 | ||
| Q4 24 | — | $3.88 | ||
| Q3 24 | — | $2.71 | ||
| Q2 24 | — | $2.40 | ||
| Q1 24 | — | $1.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $587.8M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $341.7M | $2.6B |
| 总资产 | $461.5M | $5.1B |
| 负债/权益比越低杠杆越低 | — | 0.55× |
8季度趋势，按日历期对齐
现金及短期投资CTKBWAT
| Q4 25 | $90.9M | $587.8M | ||
| Q3 25 | $93.3M | $459.1M | ||
| Q2 25 | $75.5M | $367.2M | ||
| Q1 25 | $95.3M | $382.9M | ||
| Q4 24 | $98.7M | $325.4M | ||
| Q3 24 | $162.3M | $331.5M | ||
| Q2 24 | $177.9M | $327.4M | ||
| Q1 24 | $168.8M | $338.2M |
总债务CTKBWAT
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CTKBWAT
| Q4 25 | $341.7M | $2.6B | ||
| Q3 25 | $378.6M | $2.3B | ||
| Q2 25 | $377.6M | $2.2B | ||
| Q1 25 | $379.6M | $2.0B | ||
| Q4 24 | $395.7M | $1.8B | ||
| Q3 24 | $385.5M | $1.6B | ||
| Q2 24 | $389.1M | $1.4B | ||
| Q1 24 | $392.6M | $1.3B |
总资产CTKBWAT
| Q4 25 | $461.5M | $5.1B | ||
| Q3 25 | $494.9M | $4.9B | ||
| Q2 25 | $493.3M | $4.7B | ||
| Q1 25 | $482.6M | $4.6B | ||
| Q4 24 | $499.5M | $4.6B | ||
| Q3 24 | $491.2M | $4.5B | ||
| Q2 24 | $483.7M | $4.4B | ||
| Q1 24 | $492.1M | $4.5B |
负债/权益比CTKBWAT
| Q4 25 | — | 0.55× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.89× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $164.6M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | — |
| 自由现金流率自由现金流/营收 | -2.9% | — |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | — | 0.73× |
| 过去12个月自由现金流最近4个季度 | $-8.8M | — |
8季度趋势，按日历期对齐
经营现金流CTKBWAT
| Q4 25 | $-771.0K | $164.6M | ||
| Q3 25 | $-3.9M | $187.3M | ||
| Q2 25 | $108.0K | $41.1M | ||
| Q1 25 | $-125.0K | $259.6M | ||
| Q4 24 | $2.0M | $240.1M | ||
| Q3 24 | $13.2M | $204.6M | ||
| Q2 24 | $6.2M | $54.5M | ||
| Q1 24 | $4.0M | $262.9M |
自由现金流CTKBWAT
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $3.4M | — |
自由现金流率CTKBWAT
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 7.6% | — |
资本支出强度CTKBWAT
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 1.3% | — |
现金转化率CTKBWAT
| Q4 25 | — | 0.73× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 0.28× | ||
| Q1 25 | — | 2.14× | ||
| Q4 24 | 0.21× | 1.04× | ||
| Q3 24 | 14.05× | 1.27× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | — | 2.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
WAT
暂无分部数据
